BIOMAT Database Logo BIOMAT Database Logo

Criteria for extra-label drug use debated at FDA Advisory Committee meeting. 1995

T A Raef

UI MeSH Term Description Entries
D007880 Legislation, Drug Laws concerned with manufacturing, dispensing, and marketing of drugs. Drug Laws,Food, Drug and Cosmetic Act,Narcotic Laws,Drug Legislation,Drug Law,Law, Drug,Law, Narcotic,Laws, Drug,Laws, Narcotic,Narcotic Law
D007886 Legislation, Veterinary Laws and regulations, pertaining to the field of veterinary medicine, proposed for enactment or enacted by a legislative body. Veterinary Legislation,Legislations, Veterinary,Veterinary Legislations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014486 United States Food and Drug Administration An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc. Food and Drug Administration (U.S.),USFDA,Food and Drug Administration,United States Food, Drug Administration

Related Publications

T A Raef
FDA Arthritis Advisory Committee meeting.
September 1982, Arthritis and rheumatism,
T A Raef
FDA Arthritis Advisory Committee meeting.
May 1982, Arthritis and rheumatism,
T A Raef
FDA advisory committee meeting outcomes.
June 2012, Nature reviews. Drug discovery,
T A Raef
FDA Arthritis Advisory Committee Meeting.
October 1983, Arthritis and rheumatism,
T A Raef
FDA rejects extra-label drug use proposal.
November 1983, Journal of the American Veterinary Medical Association,
T A Raef
Government affairs. FDA Arthritis Advisory Committee Meeting.
November 1983, Arthritis and rheumatism,
T A Raef
Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
March 2018, The Hastings Center report,
T A Raef
FDA advisory committee meeting on prasugrel for acute coronary syndromes.
March 2009, P & T : a peer-reviewed journal for formulary management,
T A Raef
FDA Arthritis Advisory Committee meeting: guidelines for approving nonsteroidal antiinflammatory drugs for over-the-counter use.
July 1990, Arthritis and rheumatism,
T A Raef
The rosiglitazone story--lessons from an FDA Advisory Committee meeting.
August 2007, The New England journal of medicine,
Copied contents to your clipboard!